(AP) -- Contaminated children's vaccines and other potentially serious concerns were spotted by federal regulators who combed Merck & Co.'s vaccine plant in the Philadelphia suburbs, according to a published report.
Related stories:
FDA warns Merck to clean up violations at vaccine plant
(AP) -- The Food and Drug Administration is warning drugmaker Merck & Co. to fix problems at its main vaccine plant.
Worldwide distribution of cervical cancer virus is consistent with vaccine targets
The variety of human papilloma viruses that cause invasive cervical cancer cases worldwide are largely consistent across continents, according to a new study from the University of North Carolina at Chapel Hill.
Africa's first large-scale HIV vaccine study launches
The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.
Engineer ramps up protein production, develops versatile viral spheres
Scientists are taking the amazing protein-making parts out of cells and putting them into systems to mass-produce designer proteins for a wide variety of medical uses. At the annual meeting of the American Chemical Society Sept. 13 in San Francisco, Stanford engineering Professor James Swartz will discuss advances in such "cell-free" protein synthesis, including production of versatile, nanoscale viral spheres that can act as delivery trucks for a new class of potentially more effective vaccines.
AIDS vaccine trial exceeds expectations
An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.
FDA seeks more information from Merck for cholesterol drug
(AP) -- A Merck & Co. experimental drug has been rejected by the U.S. Food and Drug Administration for the second time in four days.
FDA considers expanded use of HPV vaccine
Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.
Puzzling results from HIV vaccine trial
A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.